April 29, 2020April 29, 2020

Industry leaders seek to advance innovative resources for rare and orphan disease communities amid COVID-19 outbreak

Announcements

FFF Enterprises and BioNews announced today that both rare and orphan disease advocates are joining forces to provide patients with resources to help them connect as a community and continue ... Read more

August 11, 2014August 11, 2014

Generex Announces Publication of AE37 Prostate Cancer Vaccine Study

News

Worcester, Massachusetts-based drug developer Generex Biotechnology Corporation recently announced that the company has published follow-up study data from its Phase 1 clinical trial for treating prostate cancer with its immunotherapeutic agent AE37, a compound that is being developed ... Read more

Posts by: BNS Staff

BNS Staff

Industry leaders seek to advance innovative resources for rare and orphan disease communities amid COVID-19 outbreak

Generex Announces Publication of AE37 Prostate Cancer Vaccine Study